The present invention relates to a novel 5-amino-3-(isoxazol-3-yl)-1H-pyrazole-4-carboamycin compound having protein kinase inhibitory activity; an anticancer agent comprising the compound as an active ingredient; and an intermediate compound for the preparation of the compound.
展开▼